GL1X · GenesisL1 explorer

MolNFT v1 · #173874 · protein

Human BRR2 helicase region in complex with C-tail deleted JAB1 and mant-ADP

7BDL · U5 small nuclear ribonucleoprotein 200 kda helicase: “Human BRR2 helicase region in complex with C-tail deleted JAB1 and mant-ADP”. X-ray diffraction, 2 ligands (TG8, MG), 20 pockets (best druggability 0.84). MolNFT v1 #173874 on…

PDB
7BDL
Type
protein
Length
1,987 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
U5 small nuclear ribonucleoprotein 200 kda helicase; Pre-mRNA-processing-splicing factor 8
EC
3.6.4.13
UniProt
O75643, Q6P2Q9
Ligands
TG8, MG
Pockets
20 · best druggability 0.84

Structure

x-ray diffraction · 2 distinct chains · 39% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BU5 small nuclear ribonucleoprotein 200 kda helicase (EC 3.6.4.13)protein172542% helix, 17% strandO75643
JPre-mRNA-processing-splicing factor 8protein26221% helix, 26% strandQ6P2Q9

Ligands and binding sites

  • TG8 · [(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-2-[[oxidanyl(phosphonooxy) phosphoryl]oxymethyl]oxolan-3-yl] 2-(methylamino) benzoate · ligand · 2 copies · chains B
  • MG · Magnesium ion · metal · 2 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 14 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17520.840.8779empty
29770.800.8278empty
37850.770.8172empty
48900.750.7861TG8, MG
52550.730.8736empty

Interfaces

1 interface between chains.

  • B–J · 1773 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 7BDL · Human Brr2 Helicase Region in complex with C-tail deleted Jab1 and mant-ADP · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.